Experience

Ampersand Capital Partners

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Operating Partner

  • Apr 2022 - 1 year 9 months

  Boston, Massachusetts, United States Ampersand was founded in the late 1980s and began investing in healthcare in the early 1990s. Today, Ampersand is focused exclusively on growth equity investments in lower middle market healthcare companies. We are typically the first institutional investor in founder-owned businesses, where we work with the entrepreneur to help take the company to the next level.



P95

• Belgium
• Research Services
• 1 - 100 Employee

• Chairman of the Board

  • May 2023 - 8 months

  Leuven, Flemish Region, Belgium P95, an Ampersand portfolio company, is a global provider of epidemiology and clinical research solutions focusing on vaccines and infectious diseases. Founded in 2011 by CEO Thomas Verstaeten, previously VP Health Outcome at GSK, P95 is a leader in sourcing, analyzing, and reporting epidemiological data to assist health agencies and pharmaceutical companies in improving access to safe and effective vaccines. With offices in Europe, LATAM, Asia, and Africa the company’s services include late… Show more P95, an Ampersand portfolio company, is a global provider of epidemiology and clinical research solutions focusing on vaccines and infectious diseases. Founded in 2011 by CEO Thomas Verstaeten, previously VP Health Outcome at GSK, P95 is a leader in sourcing, analyzing, and reporting epidemiological data to assist health agencies and pharmaceutical companies in improving access to safe and effective vaccines. With offices in Europe, LATAM, Asia, and Africa the company’s services include late stage observational and clinical studies, pharmacovigilance, scientific literature reviews, related consulting work, and leads the EMA-endorsed COVIDDRIVE project. Show less



ProtaGene

• Germany
• Biotechnology Research
• 1 - 100 Employee

• Chairman of the Board

  • Apr 2022 - 1 year 9 months

  Dortmund, North Rhine-Westphalia, Germany ProtaGene is a world-leading CRO partner for the biopharmaceutical and cell and gene therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms.

• Board Member

  • Sep 2021 - Apr 2022

  Germany A leading Protein & Gene Therapy Analytical services CRO



Nexelis, a Q² Solutions Company

• Canada
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• President and CEO

  • Jan 2017 - Apr 2022

  Montreal, Canada Area Formed as a spin-out from GSK vaccines in 2015. Acquired by the management group and Ampersand Capital in July 2018 from Neomed Institute, a non for profit incubator now merged into Admare. Grown from 70 FTEs to 500 FTEs through organic and inorganic initiatives, with revenues increased 15-fold over a period of three years and a half. Sold to Q2S, an IQVIA company in January 2022 with an IRR exceeding 100%.



Ampligen Consultancy Healthcare

• Senior Advisor

  • 1998 - Jul 2018

  Brussels, Belgium A strategy/ M&A consultancy boutique adressing growth & innovation related issues in the healthcare area affiliated with IMC Integral Management consultancy, a Swiss headquartered global network of seasoned C-level individuals with a presence in 38 countries supporting small to mid-sized companies in growing their business and profit.



Mapi Group: Health Research & Commercialization

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Board member

  • 1999 - Jul 2017

  Lyon Area, France A leading global late phase CRO with clinical, observational, and consultancy (health economics, linguistic validation) activities; revenues of circa 100M€, 800 people now part of ICON..



Galien Developpement

• Chief Executive Officer, Founder

  • 2008 - 2012

  Aix en Provence, France A holding company investing in healthcare products and services retail ventures.



Puilaetco | A Quintet Private Bank

• Belgium
• Banking
• 100 - 200 Employee

• Executive Director, Head of Research, Head of Life Sciences

  • 1998 - 2002

  Brussels, Belgium European top 10 small caps broker. Today affiliated with KBC.



FDM Pharma

• Chief Executive Officer

  • 1993 - 1998

  Sophia Antipolis, France A leading Contract Research Organisation resulting from the merge between Forcing and Data Master.Revenues 1998: 240 MFF.



Forcing SA

• Managing Director, consulting

  • 1991 - 1993

  Sophia Antipolis A consultancy advising top 10 pharma/biotech/medtech companies on pre and periapproval issues



Forcing Marketing Research

• Consultant

  • 1987 - 1991

  Lille A market research boutique advising top 10 pharmaceutical companies on periapproval issues



ASTEL Laboratoires

• Registered Pharmacist

  • 1986 - 1990

  Lambersart, France A medical device company specialising in the orthopaedics field (prosthesis and bone growth induction products). Today integrated within Zimmer, a Bristol Myers Squibb company.